Keros Therapeutics, Inc. Annual Operating Margin in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Keros Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2019 to 2023.
  • Keros Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -31.3K %.
  • Keros Therapeutics, Inc. annual Operating Margin for 2023 was -113K %.
  • Keros Therapeutics, Inc. annual Operating Margin for 2021 was -280 %.
Operating Margin, Annual (%)
Period Value YoY Chg Change % Start Date End Date
2023 -113K Jan 1, 2023 Dec 31, 2023
2021 -280 Jan 1, 2021 Dec 31, 2021
2019 -106 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.